Cargando…
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
BACKGROUND: A high multiple sclerosis activity while on alemtuzumab is rather uncommon compared to moderate-efficacy drugs. The purpose of this case report is to present a case of a 37-year-old female patient with bronchial asthma and no other medical history, whose disease activity required switchi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240916/ https://www.ncbi.nlm.nih.gov/pubmed/32438901 http://dx.doi.org/10.1186/s12883-020-01789-y |